CKD患者心血管疾病的诊治进展  

Advances in the diagnosis and treatment of cardiovascular disease in chronic kidney disease patients

作　　者：陈孟华[1] 田娜[1] 

机构地区：[1]宁夏医科大学总医院肾内科,银川750004

出　　处：《中国血液净化》2017年第6期364-366,共3页Chinese Journal of Blood Purification

基　　金：宁夏自然科学基金项目编号:NT16164

摘　　要：心血管疾病(cardiovascular disease,CVD)是慢性肾脏病(Chronic kidney disease,CKD)的重要并发症和主要死亡原因。随着CKD的进展,CVD的发生率明显增高。心肾在病理生理过程中互为因果,密切相关。通常我们将CKD患者的CVD危险因素分为传统因素(与一般人群相同的危险因素)和非传统因素(与肾脏损害相关的危险因素)。CKD患者的CVD防治一方面在于早期诊断,选择适当的检查评估患者是否已存在心血管病变或是伴发心血管并发症的危险程度;另一方面,需要从延缓CKD的进展、控制CVD的危险因素和治疗终末期肾脏病的各种并发症几方面着手。Cardiovascular disease （CVD） is one of the most important complications and the primary cause of death in chronic kidney disease （CKD） patients. The incidence of CVD increases dramatically with the development of CKD. Heart and kidney are pathophysiologically interacted each other. The risk factors for CVD in CKD patients are generally divided into traditional factors （those similar in healthy people） and non- traditional factors （those specific in CKD patients）. Early prevention and treatment of CVD in CKD patients depend on the timely evaluation of CVD presentations and the risk factors for CVD and its complications and on the management of CVD progression, CVD risk factors and various complications derived from end stage renal disease.

关 键 词：慢性肾脏病 心血管疾病 危险因素 防治 

分 类 号：R318.16[医药卫生—生物医学工程]